Application 211242
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67457-852 | Norepinephrine bitartrate | Norepinephrine bitartrate | Mylan Institutional LLC | ANDA | Current |
| 67457-852 | Norepinephrine bitartrate | Norepinephrine bitartrate | Mylan Institutional LLC | ANDA | Current |
| 72078-002 | Norepinephrine bitartrate | Norepinephrine bitartrate | Mylan Institutional LLC | ANDA | Current |
| 72078-002 | Norepinephrine bitartrate | Norepinephrine bitartrate | Mylan Institutional LLC | ANDA | Current |